These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21878121)

  • 1. Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma.
    Orr KS; Shi Z; Brown WM; O'Hagan KA; Lappin TR; Maxwell P; Percy MJ
    J Exp Clin Cancer Res; 2011 Aug; 30(1):79. PubMed ID: 21878121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4.
    Kim HJ; Magesh V; Lee JJ; Kim S; Knaus UG; Lee KJ
    Oncotarget; 2015 Jun; 6(18):16287-303. PubMed ID: 25915537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of liposomal transfection of UCH-L1 siRNA on proliferation and apoptosis of lung cancer cell line H157].
    Qu X; Wang Y
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):292-6. PubMed ID: 20677552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
    Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y
    Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer.
    Luo J; Tang L; Zhang J; Ni J; Zhang HP; Zhang L; Xu JF; Zheng D
    Tumour Biol; 2014 Nov; 35(11):11541-9. PubMed ID: 25129441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients.
    Schröder C; Milde-Langosch K; Gebauer F; Schmid K; Mueller V; Wirtz RM; Meyer-Schwesinger C; Schlüter H; Sauter G; Schumacher U
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1745-55. PubMed ID: 23996067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin C-terminal hydrolase-L1 expression in non-small-cell lung cancer and its association with clinicopathological features and prognosis.
    Yu J; Yu S; Jia M; Sun PL; Gao H
    Virchows Arch; 2022 Mar; 480(3):577-585. PubMed ID: 34757486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
    Li X; Wan L; Geng J; Wu CL; Bai X
    J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of UCH-L1 Deubiquitinating Activity with Two Forms of LDN-57444 Has Anti-Invasive Effects in Metastatic Carcinoma Cells.
    Kobayashi E; Hwang D; Bheda-Malge A; Whitehurst CB; Kabanov AV; Kondo S; Aga M; Yoshizaki T; Pagano JS; Sokolsky M; Shakelford J
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
    Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis.
    Kim HJ; Kim YM; Lim S; Nam YK; Jeong J; Kim HJ; Lee KJ
    Oncogene; 2009 Jan; 28(1):117-27. PubMed ID: 18820707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathobiological implications of MUC4 in non-small-cell lung cancer.
    Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK
    J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer.
    Jin Y; Zhang W; Xu J; Wang H; Zhang Z; Chu C; Liu X; Zou Q
    Int J Clin Exp Pathol; 2015; 8(10):12500-8. PubMed ID: 26722437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1 promotes invasion of NSCLC via suppression of CDH1.
    Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
    J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.
    Agulló-Ortuño MT; Díaz-García CV; Agudo-López A; Pérez C; Cortijo A; Paz-Ares L; López-Ríos F; Pozo F; de Castro J; Cortés-Funes H; López Martín JA
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):43-53. PubMed ID: 25081930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis.
    Mei YP; Liao JP; Shen J; Yu L; Liu BL; Liu L; Li RY; Ji L; Dorsey SG; Jiang ZR; Katz RL; Wang JY; Jiang F
    Oncogene; 2012 May; 31(22):2794-804. PubMed ID: 21986946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
    Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
    Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.